Additionally, immunohistochemical analysis indicated a correlation between increased IGF2BP3 expression and chemotherapy drug resistance in bladder cancer patients, suggesting its potential involvement in mediating resistance to chemotherapy. Here, IGF2BP3 is linked to urinary bladder carcinoma.